Cellular and tissue-level rejuvenation interventions: senolytics, Yamanaka-factor reprogramming, stem cell therapies, parabiosis-derived approaches, telomerase activation, mitochondrial transplantation, and the regenerative-medicine frontier where translational research is moving fastest.
Scientists have discovered how to rebuild your cells' protective caps—telomeres—that shorten with age. New research shows telomerase activation can reduce inflammation by 62% and measurably reverse cellular aging markers.
Bioregulator peptides are short-chain amino acid sequences designed to support tissue-specific gene expression that naturally declines with age. Longevity educator Nathalie Niddam explains how personalized peptide strategies, built on solid foundations, may help restore the body's own regulatory signals.
Stem cell scientist Christian Drapeau, founder of Stemregen, reframes everything you thought you knew about stem cells. Moving beyond injections and clinical treatments, this session reveals stem cells as your body's continuous repair system—regenerating your skin monthly, your liver every few years, and even your heart over decades. Drapeau explains how declining stem cell production beginning in our 30s creates cellular deficits that drive aging, and introduces the science of endogenous stem cell mobilization: triggering your bone marrow to release more of your body's own regenerative cells for natural tissue repair and longevity optimization.
Join pioneering stem cell scientist Christian Drapeau, creator of the first stem cell supplement, as he reveals how to unlock your body's natural regenerative potential. Discover the breakthrough science of endogenous stem cell mobilization (ESCM) and learn practical strategies to harness your own stem cells for tissue repair and longevity. Drapeau will share insights from his groundbreaking work at Stemregen on how targeted supplementation can amplify your body's innate ability to heal itself, offering a revolutionary approach to health optimization that works with your biology, not against it.
Discover why measuring intracellular NAD+ levels transforms guesswork into precision optimization, helping you maintain cellular energy and vitality decades longer.
Stem cell availability declines with age, leaving tissues that once healed quickly struggling to repair. Discover how specific botanicals can increase circulating stem cells by up to 80%, restoring your body's natural renewal capacity.
Apheresis filters specific components from the blood, including lipids, inflammatory proteins, and aged plasma. Here is how it works and what the evidence shows.
Bioprinting uses 3D printing technology to build living tissues from cells and biomaterials, with potential applications in organ replacement and longevity medicine.
Cord blood banking collects and preserves stem cells from umbilical cord blood at birth for potential future medical use, including transplants and regenerative therapies.
Exosome therapy uses cell-derived vesicles to deliver regenerative signals. Learn how exosomes work, what the evidence shows, and what treatment involves.
GDF11 is a circulating protein linked to tissue rejuvenation in aging research. Learn how it works, what the evidence shows, and where the science stands.
Klotho protein is an anti-aging hormone linked to kidney function, cognition, and lifespan. Learn its mechanisms, what the research shows, and current availability.
Mesenchymal stem cell therapy uses multipotent stromal cells to modulate inflammation and support tissue repair, with evidence reviewed across conditions and delivery methods.
Mitochondrial transplantation moves healthy mitochondria into damaged cells to restore energy production, with current evidence from cardiac and neurological research.
NAD+ IV therapy delivers nicotinamide adenine dinucleotide directly into the bloodstream, bypassing digestion. Here is what the evidence says about its mechanisms and limits.
Parabiosis joins the circulatory systems of two organisms to study how blood-borne factors influence aging, tissue repair, and organ rejuvenation.
Peptide therapy uses short-chain amino acids to influence hormones, tissue repair, and immune function. Learn mechanisms, evidence, costs, and what to expect.
Plasma exchange removes and replaces blood plasma to clear harmful proteins and aged factors, with evidence on its use in autoimmune disease and aging research.
Platelet-rich plasma therapy concentrates growth factors from your own blood to support tissue repair, with evidence on joint, tendon, and skin applications.
Prolotherapy uses targeted injections of irritant solutions to stimulate connective tissue repair in joints and ligaments, addressing chronic pain at its structural source.
Prolozone therapy combines ozone gas with nutrient injections to target joint pain and tissue repair. Learn the mechanism, evidence, and what to expect.
Senolytic therapy targets senescent cells that accumulate with age, driving chronic inflammation and tissue decline. Here is how it works and where the evidence stands.
Stem cell banking preserves your youngest, healthiest cells for potential future therapies. Learn how collection, storage, and viability work.
Stem cell therapy uses undifferentiated cells to repair or replace damaged tissue. This page covers mechanisms, types, evidence, costs, and what to expect.
Stromal vascular fraction (SVF) is a cell mixture harvested from adipose tissue, containing stem cells and growth factors used in regenerative medicine.
TB-500 is a synthetic fragment of thymosin beta-4, a peptide involved in tissue repair and cell migration. Learn how it works, what the evidence shows, and key risks.
Telomerase activation refers to strategies aimed at upregulating the enzyme that rebuilds telomeres, the protective caps on chromosomes linked to cellular aging.
Xenotransplantation uses genetically modified animal organs for human transplant, addressing the organ shortage crisis. Here is how it works and where the science stands.
Yamanaka factors are four transcription factors that can reprogram adult cells to a younger state, with implications for aging and regenerative medicine.
Young plasma transfusion involves infusing blood plasma from younger donors to alter aging biology, rooted in parabiosis research with limited human evidence.
Cellular senescence—the accumulation of cells that cease dividing but resist death—has emerged as a primary target in longevity medicine due to evidence that clearing these cells extends healthspan and can address root causes of age-related disease. Senotherapeutics, including senolytics and senomorphics, are transitioning from preclinical studies to clinical trials, though significant challenges in biomarker standardization, cellular heterogeneity, and clinical efficacy remain.
Senotherapeutics—strategies that eliminate or reprogram senescent cells—represent a shift from broad-spectrum senolytic approaches toward precision interventions that target specific cell types and contexts. This progression directly addresses a fundamental mechanism of aging, offering potential to extend healthspan by restoring cellular function rather than relying solely on senescent cell elimination.
Researchers encapsulated healthy mitochondria in red blood cell membranes to deliver them into diseased cells, achieving efficient uptake and functional restoration across multiple cellular models of mitochondrial dysfunction. This addresses a long-standing barrier in mitochondrial replacement therapy and demonstrates potential for treating mitochondrial diseases and age-related energy decline.
Avaí Bio will present clinical data on an encapsulated cell therapy designed to restore circulating α-Klotho, a protein implicated in aging and metabolic regulation. The approach uses Austrianova's Cell-in-a-Box technology to sustain Klotho production, addressing a mechanism that declines with age and correlates with multiple age-related pathologies.
Klothea Bio has initiated a Phase 1b trial of AKL003, an mRNA therapy designed to elevate circulating alpha klotho protein levels in healthy adults. The trial represents a direct approach to testing whether increased klotho—a protein associated with organ protection and repair across multiple physiological systems—can favorably shift biomarkers linked to human lifespan and biological age.
Springfield Wellness Center has operated for 25 years using intravenous NAD+ therapy as part of a multimodal protocol for addiction recovery and brain restoration. The clinic's longevity and expansion suggest sustained clinical utility, though the evidence base and mechanistic clarity for NAD+ infusions in longevity contexts remain limited.
37 topics
13 topics
19 topics
23 topics
23 topics
15 topics
12 topics
21 topics
16 topics
18 topics
25 topics
17 topics
56 topics
33 topics
26 topics
24 topics
74 topics
49 topics
62 topics
23 topics
